NCT07484048

Brief Summary

Cognitive assessment plays an important part in decision making in acute neurological settings, partly because difficulties with cognitive skills such as attention, memory and executive functioning (which includes planning and problem-solving) have direct implications for patents' levels of independence and safety upon discharge. A bedside cognitive task that could shed light upon a patient's ability to demonstrate effective goal-directed behaviour (potentially along with other aspects of executive functioning such as cognitive flexibility) would be a useful addition to the existing repertoire of bedside cognitive assessments. One such test could be 'Link's Cube'. The Link's Cube Test is impractical for bedside use in an acute ward setting, as it comprises 27 small blocks. The feasibility study aims to preserve the information that is provided by Link's Cube Test (i.e. an indication of the patient's ability to engage in goal-directed behaviour) whilst altering the testing material such that only nine, slightly larger blocks are used. The objectives for the feasibility study are:

  • To identify any practical difficulties in administration of the tests that may not be apparent without trialling them
  • To generate information regarding the timing and sequence of overall administration and in particular the proposed modified Link's Cube test
  • To obtain feedback from neuropsychologists about ease of administration of the proposed new test and to obtain their views regarding potential benefits

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

January 29, 2026

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Procedural obstacles of the modified Link's Cube test.

    Assessed using the Link's Cube Scoring Matrix (total score between 0-30)

    Day 1

Study Arms (2)

Neuropsychologists

OTHER

Clinical psychologists in Gloucestershire Hospitals NHS FT

Other: Five cognitive tasks

Non-neuropsychologists

OTHER

General population, non-neuropsychologists

Other: Five cognitive tasks

Interventions

The five tests are: * Link's Cube: participants are asked to construct a large cube from 27 smaller cubes such that the outer surface is all the same colour * Modified Links' Cube: participants are asked to construct a large cube from 9 smaller blocks such that the outer surface is all the same colour, and then amend their response according to 2 further instructions * D-KEFS Tower Test - participants are asked to move discs of varying sizes across three pegs to build a target tower in as few moves as possible * Weigl test - participants are asked to sort blocks into one group according to shape/colour and then shift mental set by sorting them according to the second characteristic * Brixton Spatial Anticipation test - participants are asked to detect rules and rule changes when presented a targets that changes location

NeuropsychologistsNon-neuropsychologists

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • General population. For convenience at this feasibility study stage this will be largely comprised of colleagues working with GHT, above the age of 18, with no upper age limit.
  • Have given informed consent having followed the procedure in the protocol
  • Have the physical/sensory abilities to undertake the test procedures (e.g. use of both hands, adequate vision)
  • Sufficient English language to be able to follow test instructions

You may not qualify if:

  • Under the age of 18
  • Refusal/inability to give informed consent
  • Insufficient English language to be able to follow test instructions
  • Using cognitive testing as part of their clinical work, or ongoing familiarity with cognitive tests.
  • Working directly with the main investigator.
  • Presence of a self-reported cognitive difficulty/neurological condition - not because that in itself would be problematic for test administration or for the information generated, but rather to avoid potential distress to participants were they to find the tests administered challenging.
  • Presence of any physical/sensory/cognitive difficulty that would confound administration of the tasks, e.g. being partially sighted or having use of only one upper limb
  • clinical psychologists in GHT who have or have had a role that involves the administration of cognitive tests
  • Have given informed consent having followed the procedure in the protocol
  • Have the physical/sensory abilities to undertake the test procedures (e.g. use of both hands, adequate vision)
  • Sufficient English language to be able to follow test instructions
  • Under the age of 18
  • Refusal/inability to give informed consent
  • Insufficient English language to be able to follow test instructions
  • Presence of a self-reported cognitive difficulty/neurological condition - not because that in itself would be problematic for test administration or for the information generated, but rather to avoid potential distress to participants were they to find the tests administered challenging.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cheltenham General Hospital

Cheltenham, Gloucestershire, GL53 7AN, United Kingdom

Location

Gloucestershire Royal Hospital

Gloucester, Gloucestershire, GL1 3NN, United Kingdom

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2026

First Posted

March 19, 2026

Study Start

September 15, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations